atremorine

Atremorine is a biopharmaceutical compound derived from a specific genetic variety of *Vicia faba* (broad bean) through a non-denaturing biotechnological process. It is designed as a natural dopamine enhancer and neuroprotective agent for the management of Parkinson's disease. The product contains high concentrations of natural L-DOPA, the precursor to dopamine, and has been shown in clinical studies to significantly increase plasma dopamine levels in both treatment-naive patients and those receiving conventional anti-Parkinsonian medications. A key feature of Atremorine is its pharmacogenetic profile; its clinical efficacy and the resulting dopamine response are significantly influenced by polymorphisms in genes encoding dopamine (SLC6A3), noradrenaline (SLC6A2), and serotonin (SLC6A4) transporters.

Brand names

Atremorine

Other names

Vicia faba extractE-VIC-17024E-VIC17024E-VIC 17024